Sabra Health Care REIT Inc
F:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sabra Health Care REIT Inc
F:SBC
|
US |
|
A
|
Alaska Air Group Inc
F:ALK
|
US |
|
KH Group Oyj
F:WE3
|
FI |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
Granges AB
F:9GR
|
SE |
Wall St Price Targets
SBC Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for SBC is 20.261 EUR with a low forecast of 16.574 EUR and a high forecast of 22.671 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SBC's stock price target?
Price Target
20.261
EUR
According to Wall Street analysts, the average 1-year price target for SBC is 20.261 EUR with a low forecast of 16.574 EUR and a high forecast of 22.671 EUR.
What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.
What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.
What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.